Skip header and navigation

1 records – page 1 of 1.

[Efficacy of the lithium compound with prolonged action during "reserpine depression"]

https://arctichealth.org/en/permalink/ahliterature46357
Source
Eksp Klin Farmakol. 1997 Sep-Oct;60(5):27-30
Publication Type
Article
Author
T A Zamoshchina
A S Saratikov
Author Affiliation
Siberian State Medical University, Tomsk, Russia.
Source
Eksp Klin Farmakol. 1997 Sep-Oct;60(5):27-30
Language
Russian
Publication Type
Article
Keywords
Animals
Antidepressive Agents - pharmacology
Blepharoptosis - chemically induced - prevention & control
Body Temperature - drug effects
Circadian Rhythm
Comparative Study
Delayed-Action Preparations
Depression - chemically induced - physiopathology - prevention & control
English Abstract
Exploratory Behavior - drug effects
Hydroxybutyrates - pharmacology
Lithium Carbonate - pharmacology
Male
Organometallic Compounds - pharmacology
Rats
Abstract
A single administration of the new lithium compound with prolonged action formed on the basis of lithium oxyburate produces an antiblepharoptosis effect in rats with reserpine depression for 24 to 48 h. It optimally prevents the development of "reserpine-desynchronization" in rats when prescribed in the morning at intervals of 48 h.
PubMed ID
9483401 View in PubMed
Less detail